OptimizeRx Corp
Data quality: 100%
OPRX
Nasdaq
Services
Business Services
$6.13
▼
$0.03
(-0.49%)
Mkt Cap: 116.33 M
Price
$6.20
Mkt Cap
116.33 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 15.59% annually over 5 years — strong growth
ROE of 4.25% is below average
Debt/Equity of 0.24 — conservative balance sheet
Generating 18.66 M in free cash flow
PEG of 0.25 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.19%
Growth
Revenue Growth (5Y)
15.59%
Above sector avg (3.99%)
Revenue (1Y)18.78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
4.25%
Above sector avg (-15.85%)
ROIC5.76%
Net Margin4.69%
Op. Margin10.69%
Safety
Debt / Equity
0.24
Below sector avg (0.39)
Current Ratio3.05
Interest Coverage2.21
Valuation
PE (TTM|2027)
22.67 | 5.46
Above sector avg (-1.21)
P/B Ratio0.95
EV/EBITDA7.84
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (506 peers)
Peer Comparison
vs Services sector median (506 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.7 | -1.2 |
| P/B | 1.0 | 1.4 |
| ROE % | 4.3 | -15.8 |
| Net Margin % | 4.7 | -18.3 |
| Rev Growth 5Y % | 15.6 | 4.0 |
| D/E | 0.2 | 0.4 |
Analyst Price Target
6 analysts
Buy
Current
$6.13
Target
$14.50
$10.00
$14.00
$20.00
Forecast
Forward P/E
5.40
Forward EPS
$1.14
EPS Growth (est.)
+17.5%
Est. Revenue
120.73 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$1.14
$1.07 – $1.26
|
120.73 M | 5 |
| FY2026 |
$0.97
$0.91 – $1.02
|
111.44 M | 6 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
$0.17
$0.13 – $0.22
|
25.06 M | 6 |
| 2026 Q1 |
$0.01
-$0.06 – $0.04
|
18.35 M | 6 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | $0.22 | $0.51 | +127.4% |
| Q32025 | $0.04 | $0.20 | +438.5% |
| Q22025 | $0.02 | $0.24 | +1300.2% |
| Q12025 | -$0.12 | $0.08 | +166.7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.78% | Revenue Growth (3Y) | 23.69% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15.59% | Earnings Growth (5Y) | 91.94% |
| Profitability | |||
| Revenue (TTM) | 109.43 M | Net Income (TTM) | 5.13 M |
| ROE | 4.25% | ROA | 3.02% |
| Gross Margin | 67.25% | Operating Margin | 10.69% |
| Net Margin | 4.69% | Free Cash Flow (TTM) | 18.66 M |
| ROIC | 5.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 3.05 |
| Interest Coverage | 2.21 | Asset Turnover | 0.64 |
| Working Capital | 37.85 M | Tangible Book Value | 46.38 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 22.67 | Forward P/E | N/A |
| P/B Ratio | 0.95 | P/S Ratio | 1.06 |
| PEG Ratio | 0.25 | Forward PEG | N/A |
| EV/EBITDA | 7.84 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 16.04% | ||
| Market Cap | 116.33 M | Enterprise Value | 125.60 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.27 | Revenue / Share | 5.83 |
| FCF / Share | 0.99 | OCF / Share | 1.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | 91.68% |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.05% | FCF Conversion | 363.54% |
| SBC-Adj. FCF | 11.05 M | Growth Momentum | 3.19 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 109.43 M | 92.13 M | 71.52 M | 62.45 M | 61.29 M |
| Net Income | 5.13 M | -20.11 M | -17.57 M | -11.44 M | 378,079.0 |
| EPS (Diluted) | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 |
| Gross Profit | 73.60 M | 59.38 M | 42.90 M | 38.97 M | 35.64 M |
| Operating Income | 11.69 M | -13.71 M | -26.40 M | -12.29 M | 361,100.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 0.0 | — | — | — | — |
| SG&A Expenses | — | — | — | 33.49 M | — |
| D&A | 4.33 M | 4.33 M | 2.40 M | 2.02 M | 2.09 M |
| Interest Expense | 5.29 M | 6.16 M | 1.45 M | — | — |
| Income Tax | 1.82 M | 725,000.0 | -7.60 M | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 176.92 M | 171.17 M | 183.37 M | 134.65 M | 140.99 M |
| Total Liabilities | 48.62 M | 54.17 M | 56.82 M | 8.54 M | 9.61 M |
| Shareholders' Equity | 128.29 M | 117.00 M | 126.55 M | 126.11 M | 131.38 M |
| Total Debt | 26.29 M | 34.29 M | 38.29 M | — | — |
| Cash & Equivalents | 23.37 M | 13.38 M | 13.85 M | 18.21 M | 84.68 M |
| Current Assets | 64.72 M | 53.97 M | 54.33 M | 98.58 M | 115.11 M |
| Current Liabilities | 21.26 M | 18.65 M | 17.88 M | 8.40 M | 9.37 M |
{"event":"ticker_viewed","properties":{"ticker":"OPRX","listing_kind":"stock","pathname":"/stocks/oprx","exchange":"Nasdaq","country":"US"}}